Fluoxetine appears safer for bone health in at-risk older patients - Clinical Endocrinology News Digital Network

Fluoxetine appears safer for bone health in at-risk older patientsClinical Endocrinology News Digital NetworkThe results suggest that fluoxetine causes less bone resorption than other selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitors, or tricyclic antidepressants and “may be a safer choice for a cohort already ...